MYCN and Familial prostate cancer: The mechanisms of the MYCN-mediated repression of CDKIs are unclear; while MYCN associates more weakly with the MIZ1 repressor when compared to MYC [46,47], at least in the context of prostate cancer, MYCN can also bind and recruit the PRC2 histone methylase to repress target genes [48].